comparemela.com

Latest Breaking News On - Urologic oncology annual meeting - Page 1 : comparemela.com

ChatGPT Exhibits Poor Performance When Classifying Patients With Prostate Cancer

ChatGPT produces mixed results when evaluating patients with prostate cancer, new research suggests. ChatGPT produces mixed results when evaluating patients with prostate cancer, new research suggests.

Surgery After ICI Therapy Appears Safe for Locally Advanced RCC

Surgery after neoadjuvant treatment with immune checkpoint inhibitors is safe for patients with locally advanced RCC, a small study suggests. Surgery after neoadjuvant treatment with ICIs is safe for patients with locally advanced RCC, a small study suggests.

UGN-102 Yields CRs in 4 out of 5 Patients With Intermediate-Risk NMIBC

UGN-102 produced a high complete response rate in patients with low-grade, intermediate-risk NMIBC in the phase 3 ENVISION trial. UGN-102 produced a high complete response rate in patients with low-grade, intermediate-risk NMIBC in the phase 3 ENVISION trial.

ChatGPT Exhibits Poor Performance When Classifying Patients With Prostate Cancer

ChatGPT produces mixed results when evaluating patients with prostate cancer, new research suggests. ChatGPT produces mixed results when evaluating patients with prostate cancer, new research suggests.

Why Patients With Bladder Cancer Aren t Receiving Recommended Immunotherapy

Age, sex, insurance status, and other factors were associated with receipt of immunotherapy in a study of patients with metastatic bladder cancer. Age, sex, insurance status, and other factors were associated with receipt of immunotherapy in patients with metastatic bladder cancer.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.